<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Brief psychotic disorder</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Brief psychotic disorder</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Brief psychotic disorder</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ramin Mojtabai, MD, PhD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen Marder, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Friedman, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 28, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1439721875"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Brief psychotic disorder is a disorder defined by the presence of one or more psychotic symptoms that last for at least one day but less than one month with eventual full return to premorbid level of functioning [<a href="#rid1">1</a>]. The episode is typically associated with the experience of emotional turmoil or overwhelming confusion and may present with rapid shifts from one intense affect to another [<a href="#rid1">1</a>].</p><p>Brief psychotic disorder is often a provisional or retrospective diagnosis with a substantial rate of recurrence and subsequent diagnosis of another psychotic disorder or affective disorder with psychosis. Symptom duration is one factor distinguishing brief psychotic disorder from schizophreniform disorder (one to six months) and schizophrenia (at least six months). Differentiating brief psychotic disorder from other disorders that may present with similar symptoms is discussed below. (See <a class="local">'Differential diagnosis'</a> below.)</p><p>This topic discusses the epidemiology, pathogenesis, clinical features, assessment, diagnosis, and treatment of brief psychotic disorder. Topics related to other disorders presenting with psychosis are discussed separately. </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/17193.html" rel="external">"Psychosis in adults: Epidemiology, clinical manifestations, and diagnostic evaluation"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/130944.html" rel="external">"Psychosis in adults: Initial management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6962.html" rel="external">"Schizophrenia in adults: Clinical features, assessment, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14642.html" rel="external">"Bipolar disorder in adults: Clinical features", section on 'Psychosis'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/91774.html" rel="external">"Unipolar depression in adults: Clinical features", section on 'Psychotic'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6964.html" rel="external">"Treatment of postpartum psychosis"</a>.)</p><p></p><p class="headingAnchor" id="H1301119190"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>Other terms for psychotic syndromes with brief onset and remitting course include bouffée delirantés (in French-speaking countries) and cycloid psychosis (in German-speaking countries) [<a href="#rid1">1,2</a>]. An overlapping diagnosis (acute and transient psychotic disorder) is included in the 11<sup>th</sup> edition of the International Classification of Diseases (ICD-11) [<a href="#rid3">3</a>]. The symptoms of ICD-11 acute and transient psychotic disorder are similar to those of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) brief psychotic disorder and include delusions, hallucinations, thought process disorganization, perplexity or confusion, and disturbances of affect and mood. (See <a class="local">'Diagnosis'</a> below.)</p><p class="headingAnchor" id="H863609256"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Brief psychotic disorder is uncommon; community studies suggest the six-month to lifetime prevalence ranges from 0.05 to 2 percent. Little is known about the disorder’s epidemiology due to a very low incidence and variations in the disorder’s classification across countries. Available epidemiologic data are described below.</p><p class="bulletIndent1"><span class="glyph">●</span>The incidence of brief psychotic disorder was 1.8 per 100,000 person-years (95% CI 1.2-2.7) in the 15 years old or older population in two rural Irish communities [<a href="#rid4">4</a>]. Similarly, in a three-year follow-up study in the United Kingdom, the incidence of acute and transient psychotic disorder was 1.4 per 100,000 person-years [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the Suffolk County Study (United States), only 11 out of 547 (2.0 percent) of patients with first-admission psychosis met criteria for diagnosis of brief psychotic disorder at six months [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The prevalence of brief psychotic disorder in first episode psychosis cohorts range from 2.1 (15 out of 722) in a 44-month Australian study [<a href="#rid7">7</a>] to 5.1 percent (10 cases out of 196) in a six-year follow-up study in two rural communities in Ireland [<a href="#rid8">8</a>].</p><p></p><p class="headingAnchor" id="H1301120676"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>There are little systematic data on risk factors for brief psychotic disorder [<a href="#rid9">9</a>]. There is more information regarding risk factors for other psychotic conditions with remitting course and acute onset.</p><p class="bulletIndent1"><span class="glyph">●</span>Brief psychotic disorder is more common in women compared with men [<a href="#rid4">4,8</a>]. Transient psychotic disorders, some of which would meet the criteria for brief psychotic disorder, have also been found to be more common in women than in men [<a href="#rid5">5,10,11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A higher incidence of acute and transient psychotic disorders has been reported in resource-limited countries compared with resource-rich countries [<a href="#rid11">11,12</a>]. In the World Health Organization Determinants of Outcome Study based on 444 first onset nonaffective psychosis cases drawn from sites in eight countries, the incidence of nonaffective acute remitting psychoses were approximately 10 times higher in the two resource-limited country sites than the six resource-rich sites. The nonaffective acute remitting psychoses in that study were diagnosed based on the criteria introduced by the authors that required an acute onset (within one week) and complete remission of psychotic episode [<a href="#rid11">11</a>].</p><p></p><p class="headingAnchor" id="H1301119309"><span class="h2">Comorbidity</span><span class="headingEndMark"> — </span>Anecdotal evidence and diagnostic taxonomy have linked psychotic disorders with remitting course and acute onset with premorbid personality disorders. “Mini-psychotic” episodes as a potential feature of borderline personality disorder have been described. Research studies of the association between personality disorders and remitting psychoses with acute onset have produced mixed findings:</p><p class="bulletIndent1"><span class="glyph">●</span>In a sample of 51 patients with an acute, transient psychotic disorder in Denmark, 63 percent were diagnosed with a co-occurring personality disorder shortly after remission of psychotic symptoms [<a href="#rid13">13</a>]. The proportion of the sample diagnosed with a personality disorder decreased at one-year reassessment to 29 to 46 percent [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A sample of 42 inpatients diagnosed with acute and transient psychotic disorders was compared with a matched control group of 42 surgical inpatients with acute illnesses who were free from mental health problems on the NEO five-factor personality inventory [<a href="#rid15">15</a>]. No difference between the groups was seen on any of the five personality subscales [<a href="#rid16">16</a>].</p><p></p><p class="headingAnchor" id="H863609263"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The causes of brief psychotic disorder are not known. Limited research data and more extensive research on other psychotic disorders with remitting course and acute onset implicate:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stressful life events</strong> – Stressful life events in the period immediately preceding onset have been implicated in cases of brief psychotic disorder and in other descriptions of brief psychosis [<a href="#rid13">13,17-20</a>]. The actual prevalence of such events in the life histories of patients with brief psychotic disorder has not been systematically investigated. It is sometimes unclear in individual patients whether a stressor was a precipitant or consequence of the illness, or if it was unrelated. Case series have also described tentative links between the social and economic stresses of the coronavirus disease 2019 (COVID-19) pandemic and brief psychotic disorder [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immigration</strong> – Higher incidences of psychotic disorders with remitting course and acute onset have been found among immigrants to several resource-rich countries [<a href="#rid22">22-24</a>]. This finding may be related to higher prevalence rates of the disorder observed in resource-limited countries (see <a class="local">'Risk factors'</a> above). Another hypothesized contributing factor is heightened stress associated with discrimination and social adversity that many immigrants experience. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetics</strong> – There are little systematic data on possible contribution of genetic factors to the etiology of brief psychotic disorder. Most of the available data on the genetic risk factors are from studies of other psychotic disorders with remitting course and acute onset [<a href="#rid25">25-27</a>]. Implications of these findings for brief psychotic disorder remain unclear.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postpartum period</strong> – Many cases of psychosis in the postpartum period meet diagnostic criteria for brief psychotic disorder [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/z/d/html/6956.html" rel="external">"Postpartum psychosis: Epidemiology, clinical features, and diagnosis", section on 'Pathogenesis'</a> and  <a class="medical medical_review" href="/z/d/html/6964.html" rel="external">"Treatment of postpartum psychosis"</a>.)</p><p></p><p class="headingAnchor" id="H863609270"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Brief psychotic disorder is characterized by symptoms of psychosis lasting, by definition, between one day and one month.</p><p>Symptoms of psychosis seen in the disorder include one or more of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Hallucinations – The perception of a sensory process in the absence of an external source. Hallucinations can be auditory, visual, somatic, olfactory, or gustatory.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Delusions – A fixed, false belief. Delusions can have a persecutory, jealous, grandiose, or other content.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Disorganized speech – Disorganized speech patterns reflect disruption in the organization of person’s thoughts. Commonly observed forms of disorganized speech include tangentiality and circumstantiality.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Disorganized behavior – A patient with grossly disorganized behavior is often recognized by their inability to complete daily, normative tasks (eg, dressing and cleaning oneself, belongings in order). In some cases, disorganized behavior may manifest as catatonic behavior (eg, reduced or excessive motor activity, mutism, stereotyped movements).</p><p></p><p class="headingAnchor" id="H863609277"><span class="h1">COURSE</span><span class="headingEndMark"> — </span>Symptoms of brief psychotic disorder, by definition, remit within a month [<a href="#rid1">1</a>].</p><p>There are little systematic data on the age of onset of brief psychotic disorder though small studies suggest it may be somewhat higher than the onset of schizophrenia (eg, late teens and early 20s) [<a href="#rid11">11,25,29,30</a>]. As an example, in one study of patients with first-episode psychosis, the mean ages at presentation for brief psychotic disorder and schizophrenia were 34.7 and 30.4 years, respectively [<a href="#rid4">4</a>].</p><p>Assessment of duration of the natural history of brief psychotic disorder is often complicated by early treatment which can lead to remission of psychotic symptoms.</p><p>Many individuals who initially met criteria for a brief psychotic disorder have gone on to meet criteria for other psychotic disorders or affective disorders with psychosis [<a href="#rid9">9</a>]. In the Suffolk County study of first-admission psychosis, only 3 of the 11 patients who met the diagnostic criteria for brief psychotic disorder at six months maintained the diagnosis at two-year follow-up [<a href="#rid6">6</a>]. Three patients received diagnoses of a mood disorder, two were diagnosed with schizophrenia or schizophreniform disorder, and three others with other disorders including psychotic disorder, not otherwise specified. In a study of first episode psychosis in Ireland, only 2 of 10 patients initially diagnosed with brief psychotic disorder maintained this diagnosis six years later [<a href="#rid8">8</a>].</p><p>A study based on registry data from Denmark identified evidence of excess mortality both from natural causes and suicide in patients initially recorded as having acute and transient psychotic disorder [<a href="#rid31">31</a>].</p><p class="headingAnchor" id="H1301119621"><span class="h1">ASSESSMENT</span><span class="headingEndMark"> — </span>A comprehensive clinical assessment of a patient presenting with new onset of psychosis includes a detailed past medical history and physical examination, psychiatric history, mental status examination, exclusion of general medical and substance-related causes of psychosis, assessment for co-occurring conditions, review of prior psychiatric and family history, and assessment of recent stressors and psychosocial functioning [<a href="#rid32">32</a>]. Additionally, we obtain collateral information from the patient’s family and other supports.</p><p>In addition to the symptoms comprising diagnostic criteria for brief psychotic disorder assessment, we evaluate the patient for other features suggestive of brief psychotic disorder:</p><p class="bulletIndent1"><span class="glyph">●</span>Presence of marked stressors preceding symptom onset</p><p class="bulletIndent1"><span class="glyph">●</span>Lack of negative symptoms</p><p class="bulletIndent1"><span class="glyph">●</span>Confusion during the early course of illness</p><p></p><p>Diagnosis of brief psychotic disorder requires ongoing, longitudinal assessment of the patient’s clinical status. Because the diagnostic criteria require remission within one month, the diagnosis is initially provisional and is often retrospective. Psychotic symptoms often recur subsequent to remission, in some cases leading to a final diagnosis of schizophrenia or other psychotic disorders.</p><p>We consider the individual’s cultural and religious background in evaluating the clinical significance of the presenting symptoms. Some culturally sanctioned response patterns may mimic brief psychotic disorders. For example, individuals participating in some religious ceremonies may report hearing voices, but these are not perceived as abnormal by most members of the individual’s community. Similarly, in some cultural contexts, bereaved relatives may report hearing, seeing, or interacting with the spirit of a recently deceased loved one. These experiences are not associated with pathological sequelae and are culturally sanctioned [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H863609284"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>DSM-5-TR diagnostic criteria for brief psychotic disorder are as follows [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Presence of one or more of the following symptoms:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Delusions</p><p class="bulletIndent2"><span class="glyph">•</span>Hallucinations</p><p class="bulletIndent2"><span class="glyph">•</span>Disorganized speech</p><p class="bulletIndent2"><span class="glyph">•</span>Grossly disorganized or catatonic behavior</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Duration of an episode of the disturbance is at least a day but less than a month, with eventual full return to premorbid level of functioning.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Absence of symptoms comprising a bipolar or depressive disorder, or psychosis resulting from substance use/withdrawal or a general medical condition.</p><p></p><p>Subtypes of the disorder include:</p><p class="bulletIndent1"><span class="glyph">●</span>With marked stressor – Symptoms are preceded by and apparently in response to a markedly stressful experience. This subtype was described as brief reactive psychosis in an earlier edition of the DSM.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Without marked stressor.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>With postpartum onset – Within four weeks of delivery.</p><p></p><p class="headingAnchor" id="H1301121485"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>Distinguishing brief psychotic disorder from other affective and nonaffective psychotic conditions is often difficult. An algorithm describes the diagnostic differentiation of psychoses  (<a class="graphic graphic_algorithm graphicRef131414" href="/z/d/graphic/131414.html" rel="external">algorithm 1</a>). The paragraphs that follow describe the principal features distinguishing these disorders.</p><p class="headingAnchor" id="H1301121502"><span class="h3">Bipolar and depressive disorders</span><span class="headingEndMark"> — </span>The main diagnostic challenge is to distinguish brief psychotic disorder from affective disorders, especially bipolar disorder with psychotic features. Patients with both affective disorders and brief psychotic disorder may present with psychosis, irritability, and disorganized behavior. However, individuals with brief psychotic disorder do not manifest the mood symptoms of mania or depression. In some cases, only continued observation of the patient’s response to treatment and long-term course will clarify the diagnosis.</p><p class="headingAnchor" id="H1301121509"><span class="h3">Nonaffective psychotic disorders</span><span class="headingEndMark"> — </span>These include psychotic disorders that do not have associated affective disturbance. Longitudinal follow-up can be necessary to differentiate brief psychotic disorder from other nonaffective psychotic disorders, which typically last longer and are associated with greater long-term deficits in functioning.</p><p class="headingAnchor" id="H1301121528"><span class="h4">Schizophreniform disorder</span><span class="headingEndMark"> — </span>Schizophreniform disorder is distinguished from brief psychotic disorder by the following differences in diagnostic criteria:</p><p class="bulletIndent1"><span class="glyph">●</span>Psychotic symptoms are present for more than one month but less than six months.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Two or more types of psychotic symptoms are present for a significant proportion of a one-month period if the patient is untreated.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Negative symptoms may constitute one of the characteristic types of symptoms that are present.</p><p></p><p class="headingAnchor" id="H1301122440"><span class="h4">Schizophrenia</span><span class="headingEndMark"> — </span>Schizophrenia is distinguished from brief psychotic disorder by the following differences in diagnostic criteria (see  <a class="medical medical_review" href="/z/d/html/6962.html" rel="external">"Schizophrenia in adults: Clinical features, assessment, and diagnosis", section on 'Clinical manifestations'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Psychotic symptoms are present for at least six months.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Two or more types of psychotic symptoms must be present for a significant proportion of a one-month period if the patient is untreated.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Negative symptoms may constitute one of the characteristic types of symptoms that are present.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Functioning in one or more major areas (eg, interpersonal relationships, work, self-care) is markedly below the level achieved prior to onset.</p><p></p><p class="headingAnchor" id="H1301122618"><span class="h3">Substance-induced psychoses</span><span class="headingEndMark"> — </span>Intoxication with or withdrawal from a number of substances (including hallucinogens, cocaine, and amphetamines) are associated with acute onset of psychotic symptoms. Toxicological examination of patients presenting with psychotic symptoms of acute onset is necessary, especially in younger patients.</p><p class="headingAnchor" id="H1301122632"><span class="h3">Psychosis due to general medical conditions</span><span class="headingEndMark"> — </span>A number of neurologic (eg, seizure disorders), endocrine (eg, thyroid disease), and infectious diseases (eg, viral encephalitis) are associated with psychotic symptoms. A thorough physical examination is necessary, with laboratory testing or neuroimaging based on the findings.</p><p class="headingAnchor" id="H863609291"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>There are no evidence-based practice guidelines specifically for management of brief psychotic disorder. As such, our approach to individuals with brief psychotic disorder is typically the same as the general initial management of psychosis, regardless of cause. This includes antipsychotic medications and adjunctive supportive therapy. Management of psychosis is briefly discussed below; further discussion can be found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/130944.html" rel="external">"Psychosis in adults: Initial management", section on 'Initial management'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ensuring safety/determining site of care</strong> – The initial treatment decisions should be guided by the patient’s ability to maintain safety. This should be assessed by direct questioning about homicidal or suicidal ideation (see  <a class="medical medical_review" href="/z/d/html/1708.html" rel="external">"Suicidal ideation and behavior in adults"</a>). Other considerations include assessing patient’s ability to secure basic needs such as food and shelter. It is essential to consider collateral information obtained from family members, psychosocial supports, and other providers during the safety risk assessment and site of care determinations. (See  <a class="medical medical_review" href="/z/d/html/130944.html" rel="external">"Psychosis in adults: Initial management", section on 'Safety risk and level of care'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antipsychotic therapy</strong> – For most patients with psychosis, we suggest a second-generation antipsychotic medication. Even though some patients with brief psychotic disorder recover with supportive care only, we are unable to identify these patients at the time the decision to treat with medications needs to be made. (See <a class="local">'Course'</a> above.)</p><p></p><p class="bulletIndent1">The choice of antipsychotic is based on presenting symptoms (eg, agitation or need for sedation), patient comorbidities, and side effect profile of the medication. As examples, <a class="drug drug_general" data-topicid="9868" href="/z/d/drug information/9868.html" rel="external">risperidone</a> starting at 1 mg twice daily and titrating to therapeutic range or <a class="drug drug_general" data-topicid="8786" href="/z/d/drug information/8786.html" rel="external">aripiprazole</a> starting at 10 mg per day and titrating to therapeutic range are often good choices due to their favorable side effect profiles. Dosing, pharmacology, and adverse effects of antipsychotic medications are found on the associated tables  (<a class="graphic graphic_table graphicRef60624" href="/z/d/graphic/60624.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef82533" href="/z/d/graphic/82533.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/z/d/html/130944.html" rel="external">"Psychosis in adults: Initial management", section on 'Preference for second-generation agents'</a>.)</p><p></p><p class="bulletIndent1">Some patients with severe anxiety and agitation also warrant adjunctive treatment with short-acting benzodiazepines. This is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/291.html" rel="external">"Assessment and emergency management of the acutely agitated or violent adult"</a> and  <a class="medical medical_review" href="/z/d/html/130944.html" rel="external">"Psychosis in adults: Initial management", section on 'Psychiatric symptoms'</a>.)</p><p></p><p class="bulletIndent1">No medications have been approved by the US Food and Drug Administration specifically for treatment of brief psychotic disorder. Moreover, there are no clinical trials or case series examining the efficacy of treatments for brief psychotic disorder. Our recommendations for treatment are based on clinical experience and evidence of effective treatment for other psychotic disorders [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/z/d/html/17193.html" rel="external">"Psychosis in adults: Epidemiology, clinical manifestations, and diagnostic evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/14805.html" rel="external">"Schizophrenia in adults: Maintenance therapy and side effect management"</a> and  <a class="medical medical_review" href="/z/d/html/14808.html" rel="external">"Evaluation and management of treatment-resistant schizophrenia"</a> and  <a class="medical medical_review" href="/z/d/html/5082.html" rel="external">"Management of neuropsychiatric symptoms of dementia"</a> and  <a class="medical medical_review" href="/z/d/html/16546.html" rel="external">"Unipolar major depression with psychotic features: Acute treatment"</a>.)</p><p></p><p class="bulletIndent1">For patients who we suspect could have brief psychotic disorder (eg, psychosis improves within a month, no prior history of psychosis, and no premorbid characteristics that are concerning for chronic psychosis), we suggest continuing antipsychotic treatment for one to three months before discontinuing. As there are no widely accepted guidelines on the duration of treatment, this recommendation is based on our clinical experience. Medication should be tapered over two to four weeks, and during this time, the patient should be monitored weekly for signs of relapse.</p><p></p><p class="bulletIndent1">Longer treatment is needed if residual psychotic symptoms persist beyond one month or if the patient experiences a relapse of symptoms after stopping medication. For these patients, further evaluation and reconsideration of the diagnosis of brief psychotic disorder is warranted. (See  <a class="medical medical_review" href="/z/d/html/17193.html" rel="external">"Psychosis in adults: Epidemiology, clinical manifestations, and diagnostic evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Supportive psychotherapy</strong> – We recommend psychotherapy as an adjunct to antipsychotic therapy. No psychosocial interventions have been tested in brief psychotic disorder. Based on clinical experience, we suggest the use of supportive psychotherapy techniques such as reassurance and validation of realistic concerns. This may be particularly helpful in patients who are confused or frightened by the onset of psychotic symptoms. (See  <a class="medical medical_review" href="/z/d/html/14612.html" rel="external">"Overview of psychotherapies", section on 'Supportive psychotherapy'</a>.)</p><p></p><p class="headingAnchor" id="H165594750"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/117525.html" rel="external">"Society guideline links: Psychotic disorders"</a>.)</p><p class="headingAnchor" id="H1301122871"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Brief psychotic disorder</strong> – Brief psychotic disorder is characterized by the presence of one or more psychotic symptoms lasting for up to one month with return to premorbid level of functioning. Brief psychotic disorder is often a provisional or retrospective diagnosis and must be differentiated from other disorders presenting with similar symptoms. (See <a class="local">'Introduction'</a> above and <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology </strong>– Brief psychotic disorder is rare. Limited epidemiologic data suggest an incidence of 1.8 per 100,000 person-years. Approximately 2 to 5 percent of patients with first episode psychosis have brief psychotic disorder. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Psychotic symptoms may include hallucinations, delusions, disorganized speech or behavior. Symptoms are not better accounted for by mood disorder, other psychotic disorder, or effects of substance use. Symptoms may appear following a stressful life event. Negative symptoms are less likely to be present than in other psychotic disorders. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessment </strong>– A comprehensive clinical assessment of a patient presenting with new onset of psychosis includes a detailed history and physical examination, and assessment for co-occurring conditions. We consider the patient’s religious and cultural background in making a diagnosis. We attempt to rule out culturally sanctioned experiences that may mimic psychotic experiences. (See <a class="local">'Assessment'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – Antipsychotic medications are an effective symptomatic treatment of psychosis, regardless of underlying cause, and are the standard initial treatment for most cases. Supportive psychotherapy that offers reassurance and validation of realistic concerns may be a helpful adjunct to medication. Specific recommendations regarding selection of medication and psychotherapy as well as other aspects of acute care for acute psychosis are provided separately. (See  <a class="medical medical_review" href="/z/d/html/130944.html" rel="external">"Psychosis in adults: Initial management"</a>.)</p><p></p><p class="bulletIndent1">For patients who we suspect have brief psychotic disorder (eg, psychosis improves within a month, no prior history of psychosis, and no premorbid characteristics that are concerning for chronic psychosis), we suggest continuing treatment for at least one to three months and then slowly tapering the medication (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). We monitor patients who are tapering off medications on a weekly basis throughout the taper period and every two to three weeks thereafter for several months.</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), Washington, DC 2022.</li><li><a class="nounderline abstract_t">Castagnini A, Galeazzi GM. Acute and transient psychoses: clinical and nosological issues. BJPsych Adv 2016; 22:292.</a></li><li class="breakAll">International Classification of Diseases, Eleventh Revision (ICD-11). World Health Organization. https://icd.who.int/browse11/l-m/en (Accessed on August 14, 2023).</li><li><a class="nounderline abstract_t">Nkire N, Scully PJ, Browne DJ, et al. Systematic epidemiological and clinical comparisons across all 12 DSM-IV psychotic diagnoses in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). Psychol Med 2021; 51:607.</a></li><li><a class="nounderline abstract_t">Singh SP, Burns T, Amin S, et al. Acute and transient psychotic disorders: precursors, epidemiology, course and outcome. Br J Psychiatry 2004; 185:452.</a></li><li><a class="nounderline abstract_t">Schwartz JE, Fennig S, Tanenberg-Karant M, et al. Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Arch Gen Psychiatry 2000; 57:593.</a></li><li><a class="nounderline abstract_t">Eaton S, Harrap B, Downey L, et al. Incidence of treated first episode psychosis from an Australian early intervention service and its association with neighbourhood characteristics. Schizophr Res 2019; 209:206.</a></li><li><a class="nounderline abstract_t">Kingston T, Scully PJ, Browne DJ, et al. Diagnostic trajectory, interplay and convergence/divergence across all 12 DSM-IV psychotic diagnoses: 6-year follow-up of the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). Psychol Med 2013; 43:2523.</a></li><li><a class="nounderline abstract_t">Fusar-Poli P, Salazar de Pablo G, Rajkumar RP, et al. Diagnosis, prognosis, and treatment of brief psychotic episodes: a review and research agenda. Lancet Psychiatry 2022; 9:72.</a></li><li class="breakAll">Marneros A, Pillmann F. Acute and transient psychoses, Cambridge University Press, Cambridge, UK 2004.</li><li><a class="nounderline abstract_t">Susser E, Wanderling J. Epidemiology of nonaffective acute remitting psychosis vs schizophrenia. Sex and sociocultural setting. Arch Gen Psychiatry 1994; 51:294.</a></li><li><a class="nounderline abstract_t">Manton KG, Korten A, Woodbury MA, et al. Symptom profiles of psychiatric disorders based on graded disease classes: an illustration using data from the WHO International Pilot Study of Schizophrenia. Psychol Med 1994; 24:133.</a></li><li><a class="nounderline abstract_t">Jørgensen P, Bennedsen B, Christensen J, Hyllested A. Acute and transient psychotic disorder: comorbidity with personality disorder. Acta Psychiatr Scand 1996; 94:460.</a></li><li><a class="nounderline abstract_t">Jørgensen P, Bennedsen B, Christensen J, Hyllested A. Acute and transient psychotic disorder: a 1-year follow-up study. Acta Psychiatr Scand 1997; 96:150.</a></li><li><a class="nounderline abstract_t">Costa PT Jr, McCrae RR. Stability and change in personality assessment: the revised NEO Personality Inventory in the year 2000. J Pers Assess 1997; 68:86.</a></li><li><a class="nounderline abstract_t">Pillmann F, Blöink R, Balzuweit S, et al. Personality and social interactions in patients with acute brief psychoses. J Nerv Ment Dis 2003; 191:503.</a></li><li><a class="nounderline abstract_t">Susser E, Fennig S, Jandorf L, et al. Epidemiology, diagnosis, and course of brief psychoses. Am J Psychiatry 1995; 152:1743.</a></li><li><a class="nounderline abstract_t">Sajith SG, Chandrasekaran R, Sadanandan Unni KE, Sahai A. Acute polymorphic psychotic disorder: diagnostic stability over 3 years. Acta Psychiatr Scand 2002; 105:104.</a></li><li><a class="nounderline abstract_t">Collins PY, Wig NN, Day R, et al. Psychosocial and biological aspects of acute brief psychoses in three developing country sites. Psychiatr Q 1996; 67:177.</a></li><li><a class="nounderline abstract_t">Malhotra S, Varma VK, Misra AK, et al. Onset of acute psychotic states in India: a study of sociodemographic, seasonal and biological factors. Acta Psychiatr Scand 1998; 97:125.</a></li><li><a class="nounderline abstract_t">D Agostino A, D'Angelo S, Giordano B, et al. Brief Psychotic Disorder During the National Lockdown in Italy: An Emerging Clinical Phenomenon of the COVID-19 Pandemic. Schizophr Bull 2021; 47:15.</a></li><li><a class="nounderline abstract_t">Alexandre J, Ribeiro R, Cardoso G. Ethnic and clinical characteristics of a Portuguese psychiatric inpatient population. Transcult Psychiatry 2010; 47:314.</a></li><li><a class="nounderline abstract_t">Lau PW, Cheng JG, Chow DL, et al. Acute psychiatric disorders in foreign domestic workers in Hong Kong: a pilot study. Int J Soc Psychiatry 2009; 55:569.</a></li><li><a class="nounderline abstract_t">Littlewood R, Lipsedge M. Acute psychotic reactions in Caribbean-born patients. Psychol Med 1981; 11:303.</a></li><li><a class="nounderline abstract_t">Marneros A, Pillmann F, Haring A, et al. Features of acute and transient psychotic disorders. Eur Arch Psychiatry Clin Neurosci 2003; 253:167.</a></li><li><a class="nounderline abstract_t">Das SK, Malhotra S, Basu D. Family study of acute and transient psychotic disorders: comparison with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 1999; 34:328.</a></li><li><a class="nounderline abstract_t">Castagnini AC, Laursen TM, Mortensen PB, Bertelsen A. Family psychiatric morbidity of acute and transient psychotic disorders and their relationship to schizophrenia and bipolar disorder. Psychol Med 2013; 43:2369.</a></li><li><a class="nounderline abstract_t">Pfuhlmann B, Stöber G, Franzek E, Beckmann H. Cycloid psychoses predominate in severe postpartum psychiatric disorders. J Affect Disord 1998; 50:125.</a></li><li><a class="nounderline abstract_t">Mojtabai R, Susser ES, Bromet EJ. Clinical characteristics, 4-year course, and DSM-IV classification of patients with nonaffective acute remitting psychosis. Am J Psychiatry 2003; 160:2108.</a></li><li><a class="nounderline abstract_t">Castagnini A, Bertelsen A, Berrios GE. Incidence and diagnostic stability of ICD-10 acute and transient psychotic disorders. Compr Psychiatry 2008; 49:255.</a></li><li><a class="nounderline abstract_t">Castagnini A, Foldager L, Bertelsen A. Excess mortality of acute and transient psychotic disorders: comparison with bipolar affective disorder and schizophrenia. Acta Psychiatr Scand 2013; 128:370.</a></li><li><a class="nounderline abstract_t">Thomas P, Alptekin K, Gheorghe M, et al. Management of patients presenting with acute psychotic episodes of schizophrenia. CNS Drugs 2009; 23:193.</a></li></ol></div><div id="topicVersionRevision">Topic 14778 Version 15.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), Washington, DC 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Acute and transient psychoses: clinical and nosological issues</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Acute and transient psychoses: clinical and nosological issues</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31858926" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Systematic epidemiological and clinical comparisons across all 12 DSM-IV psychotic diagnoses in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15572734" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Acute and transient psychotic disorders: precursors, epidemiology, course and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10839338" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31130401" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Incidence of treated first episode psychosis from an Australian early intervention service and its association with neighbourhood characteristics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23480983" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Diagnostic trajectory, interplay and convergence/divergence across all 12 DSM-IV psychotic diagnoses: 6-year follow-up of the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34856200" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Diagnosis, prognosis, and treatment of brief psychotic episodes: a review and research agenda.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34856200" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Diagnosis, prognosis, and treatment of brief psychotic episodes: a review and research agenda.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8161289" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Epidemiology of nonaffective acute remitting psychosis vs schizophrenia. Sex and sociocultural setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8208878" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Symptom profiles of psychiatric disorders based on graded disease classes: an illustration using data from the WHO International Pilot Study of Schizophrenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9021000" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Acute and transient psychotic disorder: comorbidity with personality disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9272200" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Acute and transient psychotic disorder: a 1-year follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9018844" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Stability and change in personality assessment: the revised NEO Personality Inventory in the year 2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12972852" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Personality and social interactions in patients with acute brief psychoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8526240" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Epidemiology, diagnosis, and course of brief psychoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11939959" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Acute polymorphic psychotic disorder: diagnostic stability over 3 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8829242" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Psychosocial and biological aspects of acute brief psychoses in three developing country sites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9517906" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Onset of acute psychotic states in India: a study of sociodemographic, seasonal and biological factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32761196" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Brief Psychotic Disorder During the National Lockdown in Italy: An Emerging Clinical Phenomenon of the COVID-19 Pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20603391" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Ethnic and clinical characteristics of a Portuguese psychiatric inpatient population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19861344" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Acute psychiatric disorders in foreign domestic workers in Hong Kong: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7267872" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Acute psychotic reactions in Caribbean-born patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12910347" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Features of acute and transient psychotic disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10422487" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Family study of acute and transient psychotic disorders: comparison with schizophrenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23343536" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Family psychiatric morbidity of acute and transient psychotic disorders and their relationship to schizophrenia and bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9858072" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Cycloid psychoses predominate in severe postpartum psychiatric disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14638579" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Clinical characteristics, 4-year course, and DSM-IV classification of patients with nonaffective acute remitting psychosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18396184" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Incidence and diagnostic stability of ICD-10 acute and transient psychotic disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23331302" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Excess mortality of acute and transient psychotic disorders: comparison with bipolar affective disorder and schizophrenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19320529" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Management of patients presenting with acute psychotic episodes of schizophrenia.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
